Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$0.9 - $1.1 $179,683 - $219,612
-199,648 Reduced 91.46%
18,639 $18,000
Q4 2023

Feb 13, 2024

SELL
$0.74 - $1.17 $539,825 - $853,507
-729,494 Reduced 76.97%
218,287 $161,000
Q3 2023

May 14, 2024

BUY
$0.89 - $1.18 $649,249 - $860,802
729,494 Added 334.19%
947,781 $1.02 Million
Q3 2023

Nov 14, 2023

BUY
$0.89 - $1.18 $5,717 - $7,580
6,424 Added 0.68%
947,781 $1.02 Million
Q2 2023

May 14, 2024

SELL
$0.83 - $1.37 $2,475 - $4,086
-2,983 Reduced 0.32%
941,357 $941,000
Q2 2023

Aug 14, 2023

SELL
$0.83 - $1.37 $2,475 - $4,086
-2,983 Reduced 0.32%
941,357 $941,000
Q1 2023

May 14, 2024

SELL
$1.06 - $1.5 $94,341 - $133,501
-89,001 Reduced 8.61%
944,340 $1.24 Million
Q1 2023

May 11, 2023

SELL
$1.06 - $1.5 $94,341 - $133,501
-89,001 Reduced 8.61%
944,340 $1.24 Million
Q4 2022

May 14, 2024

BUY
$1.13 - $3.5 $1.13 Million - $3.51 Million
1,003,400 Added 3351.26%
1,033,341 $1.17 Million
Q4 2022

Feb 13, 2023

BUY
$1.13 - $3.5 $1.13 Million - $3.51 Million
1,003,400 Added 3351.26%
1,033,341 $1.17 Million
Q3 2022

May 14, 2024

SELL
$2.95 - $4.66 $69,469 - $109,738
-23,549 Reduced 44.03%
29,941 $97,000
Q3 2022

Nov 10, 2022

SELL
$2.95 - $4.66 $69,469 - $109,738
-23,549 Reduced 44.03%
29,941 $0
Q2 2022

May 14, 2024

SELL
$2.49 - $6.76 $410,344 - $1.11 Million
-164,797 Reduced 75.5%
53,490 $230,000
Q2 2022

Aug 15, 2022

BUY
$2.49 - $6.76 $56,137 - $152,404
22,545 Added 72.86%
53,490 $230,000
Q1 2022

May 16, 2022

SELL
$5.76 - $10.83 $731,347 - $1.38 Million
-126,970 Reduced 80.4%
30,945 $210,000
Q4 2021

Feb 14, 2022

BUY
$9.41 - $22.19 $229,622 - $541,480
24,402 Added 18.28%
157,915 $1.68 Million
Q3 2021

Nov 10, 2021

BUY
$17.88 - $24.8 $2.39 Million - $3.31 Million
133,513 New
133,513 $2.47 Million

Others Institutions Holding RPID

About RAPID MICRO BIOSYSTEMS, INC.


  • Ticker RPID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,389,100
  • Market Cap $41.8M
  • Description
  • Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumab...
More about RPID
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.